We are happy to share that we will be exhibiting at the 9th NovAliX Conference Biophysics in Drug Discovery from April 26 to 28, 2023 in Philadelphia, PA, United States.

The live event offering unprecedented social experiences will be specifically designed to enhance the meshing and mingling opportunities with peer scientists along the conference. The professionally broadcasted conference will allow distant participants to enjoy a high-quality digital experience.

This ninth edition of the NovAliX Conference aims to bring together the community of biophysicists, structural biologists, pharmacologists and medicinal chemists, to explore synergies between their disciplines to deliver better drugs on a shorter timeline.

Indeed many pharmaceutical companies have set up in-house biophysical and structural biology platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets. Academic labs involved in early-stage drug discovery also heavily rely on biophysical and structural biology techniques. And many synchrotron facilities now also include cryo-EM to offer a more complete, versatile panel of structure determination capacities, in particular for drug discovery projects.

The Conference Program will include the following Sessions:

• Biophysical Assays for PROTACs and Molecular Glues

• Covalent Drug Discovery

• Small Molecules Targeting RNA / Understanding Small-Molecule Selectivity Towards RNA

• Hybrid Methods and Technique Combinations

• Emerging Technologies - New Biophysical Approaches for Measuring Molecular Interactions